314 related articles for article (PubMed ID: 16390388)
1. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J;
Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388
[TBL] [Abstract][Full Text] [Related]
2. Short duration of breast-feeding as a risk-factor for beta-cell autoantibodies in 5-year-old children from the general population.
Holmberg H; Wahlberg J; Vaarala O; Ludvigsson J;
Br J Nutr; 2007 Jan; 97(1):111-6. PubMed ID: 17217566
[TBL] [Abstract][Full Text] [Related]
3. Asthma and allergic symptoms and type 1 diabetes-related autoantibodies in 2.5-yr-old children.
Wahlberg J; Vaarala O; Ludvigsson J;
Pediatr Diabetes; 2011 Nov; 12(7):604-10. PubMed ID: 21466648
[TBL] [Abstract][Full Text] [Related]
4. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
Seissler J; Atik Y; Klinghammer A; Scherbaum WA
Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
[TBL] [Abstract][Full Text] [Related]
5. Dietary risk factors for the emergence of type 1 diabetes-related autoantibodies in 21/2 year-old Swedish children.
Wahlberg J; Vaarala O; Ludvigsson J;
Br J Nutr; 2006 Mar; 95(3):603-8. PubMed ID: 16578935
[TBL] [Abstract][Full Text] [Related]
6. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study.
Brekke HK; Ludvigsson J
Pediatr Diabetes; 2007 Feb; 8(1):11-4. PubMed ID: 17341286
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
[TBL] [Abstract][Full Text] [Related]
9. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
[TBL] [Abstract][Full Text] [Related]
10. Daily vegetable intake during pregnancy negatively associated to islet autoimmunity in the offspring--the ABIS study.
Brekke HK; Ludvigsson J
Pediatr Diabetes; 2010 Jun; 11(4):244-50. PubMed ID: 19761530
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of diabetes-associated autoantibodies in schoolchildren: the Karlsburg Type 1 Diabetes Risk Study.
Schlosser M; Strebelow M; Rjasanowski I; Kerner W; Wassmuth R; Ziegler M
Ann N Y Acad Sci; 2004 Dec; 1037():114-7. PubMed ID: 15699502
[TBL] [Abstract][Full Text] [Related]
12. Cow's milk consumption, disease-associated autoantibodies and type 1 diabetes mellitus: a follow-up study in siblings of diabetic children. Childhood Diabetes in Finland Study Group.
Virtanen SM; Hyppönen E; Läärä E; Vähäsalo P; Kulmala P; Savola K; Räsänen L; Aro A; Knip M; Akerblom HK
Diabet Med; 1998 Sep; 15(9):730-8. PubMed ID: 9737801
[TBL] [Abstract][Full Text] [Related]
13. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
14. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk.
Hämäläinen AM; Ronkainen MS; Akerblom HK; Knip M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4249-53. PubMed ID: 11095462
[TBL] [Abstract][Full Text] [Related]
15. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
[TBL] [Abstract][Full Text] [Related]
17. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes.
Kawasaki E; Kuriya G; Satoh T; Fujishima K; Moriuchi A; Fukushima K; Ozaki M; Abiru N; Yamasaki H; Eguchi K
Ann N Y Acad Sci; 2008 Dec; 1150():248-51. PubMed ID: 19120305
[TBL] [Abstract][Full Text] [Related]
19. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
